Alpha Layer / Signal Explorer

Signal Explorer

10-K · 10-Q · 8-K · last 6 months · ← back to feed

Clear ×
Invivyd, Inc. IVVD

Showing 10-K, 10-Q & 8-K from the last 6 months. Need full history or all form types?

Sep 1, 2026 8-K 17 signals fired · top 15
Other
Rsu Psu Vesting Schedule Disclosed Non Employee Director Compensation Disclosed New York Jurisdiction Clause Classified Board Director Election Executive Severance Change Of Control Severance Payment Obligation Cause For Termination Defined Kol Endorsement Adea Waiver Release Covid19 Pandemic Uncertainty Disclosure Director Continuity Stated Ceo Team Pride Statement President Duties Defined Executive Expense Reimbursement Provision Non Solicitation Covenant
Aug 13, 2026 10-Q 32 signals fired · top 15
Other
Amendment Modification Waiver Clause Cash Flow Statement Investing Activities Net Loss Reported Executive Severance Change Of Control Severance Payment Obligation Nasdaq Minimum Bid Price Delisting Notice Financing Activities Cash Flow Disclosure New York Jurisdiction Clause Operating Lease Rent Expense Disclosed Enrollment Ahead Of Schedule Other Income Expense Disclosure Cause For Termination Defined Confidential Information Return Obligation Shares Outstanding Disclosure
Core
Indication Expansion
Aug 13, 2026 8-K 18 signals fired · top 15
Other
Net Loss Reported Sga Expense Comparison Disclosed Enrollment Ahead Of Schedule Checkpoint Inhibitor Program Interim Data Positive Revenue Increase Attribution Disclosure
Core
Patient Enrollment Velocity Clinical Trial Result Clinical Hold Combination Therapy Mentioned
Healthcare
Volume Inflecting Reimbursement Improving
Biotech v3
Ind Submission Planned
SaaS
Membership Growing Usage Growth
Jul 24, 2026 8-K 1 signal fired
Other
Nasdaq Minimum Bid Price Delisting Notice
Jul 6, 2026 8-K 5 signals fired
Biotech Risk
Accelerated Approval
Other
Checkpoint Inhibitor Program Fast Track Designation Received Covid19 Pandemic Uncertainty Disclosure
Core
Combination Therapy Mentioned
May 19, 2026 8-K 1 signal fired
Other
Classified Board Director Election
May 14, 2026 10-Q 34 signals fired · top 15
Other
Net Loss Reported Cash Flow Statement Investing Activities Financing Activities Cash Flow Disclosure Rsu Psu Vesting Schedule Disclosed Credit Risk Management Disclosure Operating Lease Rent Expense Disclosed Interim Data Positive Segment Aggregation Disclosure Credit Agreement Schedule Amendment Other Income Expense Disclosure Transfer And Demand Rights Limitations Covid19 Workplace Safety Measures Stock Option Intrinsic Value Disclosure Pension Contribution Disclosure
Core
Clinical Trial Result
May 14, 2026 8-K 9 signals fired
Core
Clinical Trial Result Clinical Hold Indication Expansion Combination Therapy Mentioned
Other
Patient Retention High Enrollment Ahead Of Schedule Ceo Team Pride Statement Fda Aligned Interim Data Positive
Apr 9, 2026 8-K 12 signals fired
Other
Ceo Team Pride Statement Kol Endorsement Safety Differentiated Interim Data Positive Fda Aligned Enrollment Ahead Of Schedule Fast Track Designation Received
Core
Clinical Trial Result Indication Expansion Clinical Hold Combination Therapy Mentioned Lead Asset Progress